Hellenic Institute For The Study Of Sepsis
Clinical trials sponsored by Hellenic Institute For The Study Of Sepsis, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug aims to tame overactive immune response in sepsis Results expected Nov 2026 (estimated)
-
New drug combo shows promise against deadly gut infection
Disease control CompletedThis study tested whether adding the drug bezlotoxumab to standard treatment could prevent serious outcomes in people with a severe C. diff infection. Researchers used a special score to identify 44 high-risk patients. The goal was to see if the drug reduced organ failure, infect…
Phase 2 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Clotting clues: simple blood test eyed to catch sepsis before it turns deadly
Diagnosis CompletedResearchers want to know whether a bedside device that measures how blood clots can predict which patients with an infection will develop sepsis. The study enrolls 147 adults arriving at an emergency department with a suspected infection. Everyone gives blood for the clotting mon…
Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Diagnosis
Last updated Sep 21, 2026 20:00 UTC